Home › NDC Lookup › Ingredients › Salicylic Acid › 73391-0103-02
Organic Fruits Acne Spot Treatment - Yuja (1% Salicylic Acid) .3 g/30g Cream — NDC 73391-0103-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Organic Fruits Acne Spot Treatment - Yuja (1% Salicylic Acid) .3 g/30g Cream — NDC 73391-0103-2 (Billing 73391-0103-02)

by ENS KOREA Co., Ltd. · 1 TUBE in 1 PACKAGE / 30 g in 1 TUBE

This is a package of Organic Fruits Acne Spot Treatment - Yuja (1% Salicylic Acid) .3 g/30g Cream from ENS KOREA Co., Ltd., marketed since Oct 2025 and currently FDA-listed. It is this product's only package size.

NDC 73391-0103-02
🏷️ FDA NDC (as labeled) 73391-0103-2 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 73391-0103-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
73391 labeler · 0103 product · 2 package
Package marketed since
Oct 24, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC)
8800314440118
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 73391-0103-2
Product NDC 73391-0103
11-digit billing NDC 73391010302
RxCUI 417424
UNII O414PZ4LPZ, 15FIX9V2JP, SOI2LOH54Z
UPC 8800314440118
Application # M006
SPL Set ID 34f9688d-efa1-1d3f-e063-6294a90ab127
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-10-24
Route TOPICAL
Dosage form CREAM
Substance SALICYLIC ACID
Quick answers
  • RxCUI (RxNorm): 417424
Why two NDCs? The FDA registers this code as 73391-0103-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 73391-0103-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
73391-0103-02 You're viewing this Main listing 1 TUBE in 1 PACKAGE / 30 g in 1 TUBE 2025-10-24 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Acne Advanced Clarifying Hydrator 10 mg/mL 15751-3030-02 Eminence 1 bottle — — FDA listed —
blackhead solutions self-heating blackhead extractor acne medication 10 mg/mL 49527-0061-01 CLINIQUE 1 tube — — Discontinued —
clear days ahead oil-free salicylic acid acne treatment and moisturizer .6 g/60mL 50184-1010-01 Philosophy 60 ml — — FDA listed —
Organic Fruits Acne Spot Treatment - Yuja (1% Salicylic Acid) .3 g/30gthis 73391-0103-02 ENS 1 tube — — FDA listed —
Acne Calming Water Cream 10 mg/mL 76354-0416-01 e.l.f. 1 bottle — — FDA listed —
The Inkey List Succinic Acid Acne Treatment 10 mg/mL 81136-0017-01 Brand 15 ml — — Discontinued —
Blemish Spot Treatment .01 g/g 83657-0472-01 Skin 15 g — — FDA listed —
AOSORW Folliculitis and Acne Treatment Cream 1 g/100g 85498-0012-01 SpineStatus 100 g — — FDA listed —
Milia remover .01 g/mL 87278-0005-01 Guangxi 15 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Oct 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Salicylic Acid Topical inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • 12.9 g / 30 g UNII 24H4NWX5CO
    Kaolin is a naturally occurring clay mineral. It's used in tablets and capsules as a filler and absorbent to add bulk, improve texture, and help bind ingredients together.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also states*Pyrus Pyrifolia (Pear) Fruit Extract, *Lentinus Edodes Extract, △Coco-Caprylate/Caprate, **Sorbitan Olivate, **Polyglyceryl-2 Dipolyhydroxystearate, △Polyglyceryl-3 Polyricinoleate, *Copernicia Cerifera (Carnauba) Wax, **Cetearyl Alcohol, Chamaecyparis Obtusa Leaf Extract, **Polyhydroxystearic Acid, △Isostearic Acid, *Calendula Officinalis Flower Oil, Pyrus Communis (Pear) Flower Extract, *Vitis Vinifera (Grape) Seed Oil, **Cetyl Alcohol, Paeonia Suffruticosa Root Extract, Scutellaria Baicalensis Root Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Tuber Magnatum Extract, Inonotus Obliquus (Mushroom) Extract, Hericium Erinaceum (Mushroom) Extract, *Lactobacillus/Pear Juice Ferment Filtrate, *Persea Gratissima (Avocado) Butter, *Theobroma Cacao (Cocoa) Seed Butter, Propanediol, *Lactobacillus Plantarum/Pyrus Communis (Pear) Fruit/Pyrus Communis (Pear) Flower Ferment Filtrate, Pimpinella Anisum (Anise) Fruit Extract, Vanilla Planifolia Fruit Extract, Pyrus Malus (Apple) Fruit Extract, Cocos Nucifera (Coconut) Oil, Rosa Damascena Flower Aqua(Water/Eau), Hedera Helix (Ivy) Leaf/Stem Extract, Musa Sapientum (Banana) Flower Extract, Asiatic Acid, Aqua(Water/Eau), Alcohol, Madecassic Acid, Asiaticoside, Fragaria Chiloensis (Strawberry) Fruit Extract. (*Certified Organically Grown **Natural Origin △Ecocert) / 54% Organic of Total

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerENS KOREA Co., Ltd.
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code73391
First marketedOct 2025
Product typeHuman Otc Drug
Portfolio3 products on file

More NDCs from ENS KOREA Co., Ltd. labeler code 73391

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 37 words ▾

• apply liberally 15 minutes before sun exposure • reapply: – after 80 minutes of swimming or sweating – immediately after towel drying – at least every 2 hours • children under 6 months: Ask a doctor

⏱️ Dosage and Administration 30 words ▾

• Helps prevent sunburn • If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

⚠️ Warnings 56 words ▾

For external use only Do not use • on damaged or broken skin When using this product • keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if • rash occurs Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Inactive Ingredients 149 words ▾

*Pyrus Pyrifolia (Pear) Fruit Extract, *Lentinus Edodes Extract, △Coco-Caprylate/Caprate, **Sorbitan Olivate, **Polyglyceryl-2 Dipolyhydroxystearate, △Polyglyceryl-3 Polyricinoleate, *Copernicia Cerifera (Carnauba) Wax, **Cetearyl Alcohol, Chamaecyparis Obtusa Leaf Extract, **Polyhydroxystearic Acid, △Isostearic Acid, *Calendula Officinalis Flower Oil, Pyrus Communis (Pear) Flower Extract, *Vitis Vinifera (Grape) Seed Oil, **Cetyl Alcohol, Paeonia Suffruticosa Root Extract, Scutellaria Baicalensis Root Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Tuber Magnatum Extract, Inonotus Obliquus (Mushroom) Extract, Hericium Erinaceum (Mushroom) Extract, *Lactobacillus/Pear Juice Ferment Filtrate, *Persea Gratissima (Avocado) Butter, *Theobroma Cacao (Cocoa) Seed Butter, Propanediol, *Lactobacillus Plantarum/Pyrus Communis (Pear) Fruit/Pyrus Communis (Pear) Flower Ferment Filtrate, Pimpinella Anisum (Anise) Fruit Extract, Vanilla Planifolia Fruit Extract, Pyrus Malus (Apple) Fruit Extract, Cocos Nucifera (Coconut) Oil, Rosa Damascena Flower Aqua(Water/Eau), Hedera Helix (Ivy) Leaf/Stem Extract, Musa Sapientum (Banana) Flower Extract, Asiatic Acid, Aqua(Water/Eau), Alcohol, Madecassic Acid, Asiaticoside, Fragaria Chiloensis (Strawberry) Fruit Extract.

(*Certified Organically Grown **Natural Origin △Ecocert ) / 54% Organic of Total

🎯 Purpose 30 words ▾

• Helps prevent sunburn • If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

📄 Keep Out of Reach of Children 13 words ▾

If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 37 words ▾

Label

WHAMISA ORGANIC FRUITS ACNE SPOT TREATMENT - YUJA WHAMISA ORGANIC FRUITS ACNE SPOT TREATMENT - YUJA WHAMISA ORGANIC FRUITS ACNE SPOT TREATMENT - YUJA

WHAMISA ORGANIC PEAR BLOSSOM SUNSCREEN POWDER_Artwork WHAMISA ORGANIC PEAR BLOSSOM SUNSCREEN POWDER

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by ENS KOREA Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
ENS KOREA Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 73391-0102-02 · ENS 73402-0111-01 · Zhejiang →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.